A study by Kamal et al. (2025) [41] examined PTPRC, also known as CD45, and reported that the progressive loss of CD45 pos/CD138 low and CD45 low/CD138 low PC clusters, which were prevalent in control and precursor samples, but significantly diminished with MM advancement. Here, PTPRC is linked to Miyoshi myopathy.